No of patients | Sex | Age (years) | Localization | Tumor Characteristic | No of treatments | Duration of individual months follow up | Response |
---|---|---|---|---|---|---|---|
1 | F | 62 | Nose | G1 | 1 | 22 | CR |
2 | M | 78 | Scalp | G1 | 1 | 36 | PR |
3 | M | 75 | Nose | G1 | 1 | 31 | PR |
4 | M | 72 | Ear | G2 | 1 | 5 | CR |
5 | M | 64 | Back | G3 | 1 | 36 | PR |
6 | M | 69 | Forehead | G1 | 1 | 41 | PR |
7 | M | 53 | Foot | G3 | 2 | 48 | CR |
8 | M | 54 | Foot | G2 | 3 | 40 | PD |
9 | M | 73 | Foot | G2 | 1 | 24 | PR |
10 | F | 51 | Nose | G1 | 1 | 26 | CR |
11 | M | 64 | Lip | G2 | 2 | 37 | PR |
12 | M | 87 | Scalp | G2 | 2 | 40 | SD |
13 | M | 65 | Foot | G2 | 1 | 26 | CR |
14 | F | 52 | Cheek | G1 | 1 | 34 | PR |
15 | F | 84 | Scalp | G1 | 1 | 26 | SD |
16 | M | 80 | Ear | G2 | 1 | 28 | PD |
17 | F | 74 | Cheek | G1 | 2 | 36 | PR |
18 | M | 88 | Scalp | G2 | 1 | 31 | PR |
19 | F | 75 | Scalp | G1 | 2 | 38 | SD |
20 | M | 78 | Scalp | G1 | 2 | 35 | PR |
21 | F | 82 | Nape | G1 | 1 | 34 | PR |
22 | M | 51 | Leg | G1 | 1 | 32 | PR |